Intratumoral Heterogeneity of ERBB2 Amplification and HER2 Expression in Micropapillary Urothelial Carcinoma.

about

Intratumoral Heterogeneity of ERBB2 Amplification and HER2 Expression in Micropapillary Urothelial Carcinoma.

Item

http://www.wikidata.org/entity/Q52618828

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@en

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@nl

type

Item

label

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@en

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@nl

prefLabel

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@en

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@nl

P1476

Intratumoral Heterogeneity of ...... apillary Urothelial Carcinoma.

@en

P2093

Anuradha Gopalan

http://www.w3.org/2001/XMLSchema#string

Bernard H Bochner

http://www.w3.org/2001/XMLSchema#string

Byron H Lee

http://www.w3.org/2001/XMLSchema#string

David B Solit

http://www.w3.org/2001/XMLSchema#string

Dean F Bajorin

http://www.w3.org/2001/XMLSchema#string

François Audenet

http://www.w3.org/2001/XMLSchema#string

Gopa Iyer

http://www.w3.org/2001/XMLSchema#string

Gouri Nanjangud

http://www.w3.org/2001/XMLSchema#string

Guido Dalbagni

http://www.w3.org/2001/XMLSchema#string

Harry W Herr

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Comprehensive molecular characterization of urothelial bladder carcinoma

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies.

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.

P31

scholarly article

P356

10.1016/J.HUMPATH.2018.03.015

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29601842

http://www.w3.org/2001/XMLSchema#string

P932

6019182

http://www.w3.org/2001/XMLSchema#string